FAIR LAWN, N.J.--(BUSINESS WIRE)--Vyteris, Inc. (OTCBB: VYHN), developer of the first FDA-approved active patch transdermal drug delivery system, announces the appointments of John E. Burrows and Susan P. Guerin to the company’s board of directors, both of which became effective earlier in 2008. Burrows serves on the company’s audit committee, while Guerin also serves on the company’s audit committee and is the chairperson of the company’s compensation committee.
